Fat elimination in acute renal failure: long-chain vs medium-chain triglycerides

Open Access
Publisher Website
Google Scholar
Abstract
Elimination and hydrolysis of fat emulsions containing long-chain (LCT; Intralipid®) or long- and medium-chain triglycerides (MCT; Lipofundin MCT®) were compared in seven patients with acute renal failure (ARF) and six healthy control subjects. In control subjects, clearance of MCT was slightly higher than that of LCT (1.93 ± 0.34 vs 1.55 ± 0.3 mL · kg body wt−1 · min−1, P < 0.05). The rise in plasma triglycerides was similar and the release of free fatty acids was higher during MCT (P < 0.02). In ARF, clearance of both LCT and MCT was equally reduced (0.53 ± 0.12 vs 0.59 ± 0.14 mL · kg body wt−1 · min−1, P < 0.01 vs control subjects). Again, the rise in triglycerides was comparable. Free fatty acid release was higher during MCT but lower than in control subjects. Plasma concentrations of glucose and lactate were not affected in control subjects but increased during both LCT and MCT in ARF. Thus elimination of both LCT and MCT is profoundly decreased in ARF. The impaired lipolysis in ARF cannot be circumvented by the use of MCT.